Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria
Open Access
- 1 April 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 102 (4) , 855-860
- https://doi.org/10.1111/j.1476-5381.1991.tb12266.x
Abstract
McNeil A 343 (10 μm‐30 μm) enhanced the fractional stimulation‐induced (S‐I) outflow of radioactivity from mouse isolated atria which had been incubated with [3H]‐noradrenaline. The enhancing effect of McNeil A 343 was not altered by hexamethonium (300 μm) suggesting that it was not due to an action at nicotinic receptors. It is also unlikely that McNeil A 343 enhanced the S‐I outflow of radioactivity in mouse atria by blocking neuronal reuptake of noradrenaline since the effect persisted in the presence of cocaine (30 μm). The facilitatory effect of McNeil A 343 on the S‐I outflow of radioactivity was attenuated by atropine (0.3 μm), pirenzepine (0.2 μm or 1.0 μm), dicyclomine (1.0 μm) and methoctramine (1.0 μm) and was thus due to activation of muscarinic receptors. In contrast to the effect of McNeil A 343, another muscarinic receptor agonist, carbachol (3.0 μm) significantly decreased the S‐I outflow of radioactivity. The receptors through which McNeil A 343 acts to enhance the S‐I outflow of radioactivity appear to be distinct from inhibitory prejunctional muscarinic receptors. The relatively M1‐selective antagonist, pirenzepine (0.2 μm), attenuated the facilitatory effect of McNeil A 343 whereas a higher concentration (1.0 μm) was required to block the inhibitory effect of carbachol. Conversely, the relatively M2‐selective antagonist, methoctramine (0.1 μm), blocked the inhibitory effect of carbachol but a higher concentration of methoctramine (1.0 μm) was required to block the facilitatory effects of McNeil A 343. These results tentatively ascribe facilitatory muscarinic receptors as belonging to the M1 subtype and inhibitory muscarinic receptors as belonging to the M2 subtype. The non‐selective muscarinic receptor antagonist, atropine, enhanced the S‐I outflow of radioactivity, suggesting that there was tonic activation of inhibitory prejunctional muscarinic receptors by endogenous acetylcholine released from parasympathetic nerves. However, pirenzepine (0.03 μm–1.0 μm) did not decrease the S‐I outflow of radioactivity, suggesting that under the conditions of the present study, facilitatory muscarinic receptors are not tonically activated by endogenous acetylcholine.Keywords
This publication has 30 references indexed in Scilit:
- Dual Effect of the Muscarinic Agonist McN-A-343 on Vascular Neuroeffector TransmissionActa Pharmacologica et Toxicologica, 2009
- Muscarinic receptor differentiationPharmacology & Therapeutics, 1988
- Muscarinic Receptor Subtypes and the Selectivity of Agonists and AntagonistsPharmacology, 1988
- Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptorsJournal of Medicinal Chemistry, 1987
- MUSCARINIC RECEPTOR SUBTYPES: A CRITIQUE OF THE CURRENT CLASSIFICATION AND A PROPOSAL FOR A WORKING NOMENCLATUREJournal of Autonomic Pharmacology, 1986
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Sympathetic nerve stimulation on the perfused rat heartNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- Modulation by the Muscarinic Agonist McN-A-343 of Noradrenaline Release from Vascular Sympathetic NeuronesJournal of Cardiovascular Pharmacology, 1980
- Regulation of noradrenaline release by presynaptic receptor systemsPublished by Springer Nature ,1977
- Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog.Circulation Research, 1976